121 related articles for article (PubMed ID: 17627462)
1. New approaches in systemic treatment of advanced colorectal cancer: the molecular targets era.
Capdevila J; Mendez G; Macarulla T; Ramos FJ; Casado E; Tabernero J
Expert Rev Anticancer Ther; 2007 Jul; 7(7):1027-41. PubMed ID: 17627462
[TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic approaches for metastatic colorectal cancer.
Hoff PM
Oncology (Williston Park); 2000 Nov; 14(11A):217-20. PubMed ID: 11195413
[TBL] [Abstract][Full Text] [Related]
3. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for response to chemotherapy in colorectal cancer patients.
Vincenzi B; Cesa AL; Santini D; Schiavon G; Grilli C; Graziano F; Tonini G
Crit Rev Oncol Hematol; 2004 Oct; 52(1):45-60. PubMed ID: 15363466
[TBL] [Abstract][Full Text] [Related]
6. The impact of perioperative blood transfusion on clinical outcomes in colorectal surgery.
Dionigi G; Rovera F; Boni L; Carrafiello G; Recaldini C; Mangini M; Laganà D; Bacuzzi A; Dionigi R
Surg Oncol; 2007 Dec; 16 Suppl 1():S177-82. PubMed ID: 18023576
[TBL] [Abstract][Full Text] [Related]
7. [Systemic treatment of metastatic colorectal cancer].
Montemurro M; Achtari L; Röth A; Halkic N; Luthi F; Ozsahin M; Denys A; Bauer J; Demartines N; Leyvraz S
Rev Med Suisse; 2008 May; 4(158):1254-7. PubMed ID: 18616207
[TBL] [Abstract][Full Text] [Related]
8. Advances in chemotherapy against advanced or metastatic colorectal cancer.
Omura K
Digestion; 2008; 77 Suppl 1():13-22. PubMed ID: 18204257
[TBL] [Abstract][Full Text] [Related]
9. The development of novel agents for the treatment of colorectal cancer: a critical review of current practice and some suggestions for the future.
Marshall JL; Gehan EA
Clin Adv Hematol Oncol; 2007 Mar; 5(3):167-72. PubMed ID: 17519876
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy for metastatic colorectal cancer].
Iwasa S; Shimada Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
[TBL] [Abstract][Full Text] [Related]
11. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
Atreya I; Neurath MF
Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
[TBL] [Abstract][Full Text] [Related]
12. Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies.
Yau T; Chan P; Ching Chan Y; Wong BC; Liang R; Epstein RJ
Aliment Pharmacol Ther; 2008 Jun; 27(11):997-1005. PubMed ID: 18363897
[TBL] [Abstract][Full Text] [Related]
13. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
14. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
[TBL] [Abstract][Full Text] [Related]
15. First-line chemotherapy in metastatic colorectal cancer: new approaches and therapeutic algorithms. Always hit hard first?
Loupakis F; Masi G; Vasile E; Falcone A
Curr Opin Oncol; 2008 Jul; 20(4):459-65. PubMed ID: 18525344
[TBL] [Abstract][Full Text] [Related]
16. [Colorectal cancer in elderly patients].
Des Guetz G; Carola E
Rev Med Suisse; 2009 May; 5(204):1116-8, 1120, 1122-3. PubMed ID: 19580209
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life as a valid outcome in the treatment of advanced colorectal cancer.
Byrne C; Griffin A; Blazeby J; Conroy T; Efficace F
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S95-104. PubMed ID: 18039559
[TBL] [Abstract][Full Text] [Related]
18. The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.
Chiappa A; Makuuchi M; Lygidakis NJ; Zbar AP; Chong G; Bertani E; Sitzler PJ; Biffi R; Pace U; Bianchi PP; Contino G; Misitano P; Orsi F; Travaini L; Trifirò G; Zampino MG; Fazio N; Goldhirsch A; Andreoni B
Crit Rev Oncol Hematol; 2009 Oct; 72(1):65-75. PubMed ID: 19147371
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
Wallerand H; Reiter RR; Ravaud A
Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
